Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

NCT ID: NCT05922605

Last Updated: 2023-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-20

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious.

Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Forty-four children scheduled for hypospadias randomize into 2 groups. Group E (n=22) (0.2% ropivacaine 0.7 ml/kg and S-ketamine 0.5 mg/kg), group C(n=22)( 0.2%ropivacaine 0.7ml/kg and equivalent saline) intraoperative and postoperative hemodynamics will be recorded. Postoperative pain is assessed using an established 6-item FLACC score at 1h,3h,6h,12h,24h,48h, or the time when children complain of pain after surgery. A score of more15μg/kg is administered.Investigators propose to compare the duration of caudal analgesia provided by plain ropivacaine and by a mixture of ropivacaine and S-ketamine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Analgesia S-ketamine Pediatrics Caudal Block Hypospadias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel Assignment
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
The Patients allocated to study groups using computer generates random list \& group assignment is sealed in sequentially numbered opaque envelopes that open after induction of anesthesia.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group E

the children are given a mixture of 0.2%ropivacaine 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg for caudal analgesia.

Group Type EXPERIMENTAL

S-ketamine & Ropivacaine

Intervention Type DRUG

The experiment group (Group E) will receive a mixture of ropivacaine 0.2% 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.

Group C

The children are given 0.2%ropivacaine 0.7 ml/kg and saline of equal volume caudally.

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

The experiment group (Group C) will receive ropivacaine 0.2% 0.7 ml/kg plain and equial volume saline caudally for postoperative analgesia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

S-ketamine & Ropivacaine

The experiment group (Group E) will receive a mixture of ropivacaine 0.2% 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.

Intervention Type DRUG

Ropivacaine

The experiment group (Group C) will receive ropivacaine 0.2% 0.7 ml/kg plain and equial volume saline caudally for postoperative analgesia.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* informed parent consent, ASA I or II children, between 3months and 18 years of age,and weighing \<28kg, scheduled for elective hypospadias surgery with general anesthesia will be recruited.

Exclusion Criteria

* Patients who have congenital abnormalities of lower spine and meninges.
* Patients with hypersensitivity to any local anesthetics
* Children with coagulation disorders
* Presence of Infections at puncture sites
* Preexisting neurological disease
* Refusal to consent by parent/guardian
Minimum Eligible Age

3 Months

Maximum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tao Zhang

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tao Zhang

Associate Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tao Zhang, M.D.

Role: STUDY_CHAIR

First Affiliated Hospital, Sun Yat-Sen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

tao Zhang, MD

Role: CONTACT

8613580482938

weiyi Xu, B.M

Role: CONTACT

8619875691896

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

xia Feng, MD

Role: primary

8613688877856

References

Explore related publications, articles, or registry entries linked to this study.

Gunes Y, Secen M, Ozcengiz D, Gunduz M, Balcioglu O, Isik G. Comparison of caudal ropivacaine, ropivacaine plus ketamine and ropivacaine plus tramadol administration for postoperative analgesia in children. Paediatr Anaesth. 2004 Jul;14(7):557-63. doi: 10.1111/j.1460-9592.2004.01220.x.

Reference Type BACKGROUND
PMID: 15200652 (View on PubMed)

De Negri P, Ivani G, Visconti C, De Vivo P. How to prolong postoperative analgesia after caudal anaesthesia with ropivacaine in children: S-ketamine versus clonidine. Paediatr Anaesth. 2001 Nov;11(6):679-83. doi: 10.1046/j.1460-9592.2001.00742.x.

Reference Type BACKGROUND
PMID: 11696143 (View on PubMed)

Weber F, Wulf H. Caudal bupivacaine and s(+)-ketamine for postoperative analgesia in children. Paediatr Anaesth. 2003 Mar;13(3):244-8. doi: 10.1046/j.1460-9592.2003.01018.x.

Reference Type BACKGROUND
PMID: 12641687 (View on PubMed)

Martindale SJ, Dix P, Stoddart PA. Double-blind randomized controlled trial of caudal versus intravenous S(+)-ketamine for supplementation of caudal analgesia in children. Br J Anaesth. 2004 Mar;92(3):344-7. doi: 10.1093/bja/aeh076. Epub 2004 Jan 22.

Reference Type BACKGROUND
PMID: 14742331 (View on PubMed)

Koinig H, Marhofer P, Krenn CG, Klimscha W, Wildling E, Erlacher W, Nikolic A, Turnheim K, Semsroth M. Analgesic effects of caudal and intramuscular S(+)-ketamine in children. Anesthesiology. 2000 Oct;93(4):976-80. doi: 10.1097/00000542-200010000-00017.

Reference Type BACKGROUND
PMID: 11020749 (View on PubMed)

Brenner L, Marhofer P, Kettner SC, Willschke H, Machata AM, Al-Zoraigi U, Lundblad M, Lonnqvist PA. Ultrasound assessment of cranial spread during caudal blockade in children: the effect of different volumes of local anaesthetics. Br J Anaesth. 2011 Aug;107(2):229-35. doi: 10.1093/bja/aer128. Epub 2011 Jun 3.

Reference Type BACKGROUND
PMID: 21642642 (View on PubMed)

Narasimhan P, Kashyap L, Mohan VK, Arora MK, Shende D, Srinivas M, Kashyap S, Nath S, Khanna P. Comparison of caudal epidural block with paravertebral block for renal surgeries in pediatric patients: A prospective randomised, blinded clinical trial. J Clin Anesth. 2019 Feb;52:105-110. doi: 10.1016/j.jclinane.2018.09.007. Epub 2018 Sep 19.

Reference Type BACKGROUND
PMID: 30243061 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Caudal S-ketamine

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Efficacy Evaluation of S (+) - Ketamine in Children
NCT04834427 ENROLLING_BY_INVITATION PHASE4